Interestingly, solute carrier family 2 member 1 (SLC2A1) was recently found in a prognostic prediction model for lung adenocarcinoma (LUAD) patients based on a metabolism-associated gene signature64. The gene discussed is SLC2A1; the disease is lung adenocarcinoma.